FDA Inspection
Colgate-Palmolive CompanyColgate-Palmolive Company – FDA Inspection, Aug 20, 2025
Record Details
This FDA Inspection record concerns Colgate-Palmolive Company, with an inspection on August 20, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d5b9d832-2fa9-4fc4-8c26-3f0f4f9336fe
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1280473
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Colgate-Palmolive Company
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 26, 2024 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 30, 2019 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 31, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Colgate-Palmolive Company
- FDA Inspection 1233220 - 2024-02-16
- FDA Inspection 1228569 - 2024-01-26
- FDA Inspection 1091323 - 2019-05-30
- FDA Inspection 1041194 - 2017-10-31
- FDA Inspection 833599 - 2013-05-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.